<DOC>
	<DOCNO>NCT01485367</DOCNO>
	<brief_summary>This open label 6 month pilot study male female participant age 52 desire treatment prevention senile purpura forearm . This study evaluate effect Adapalene 0.3 % use treatment prevention senile purpura .</brief_summary>
	<brief_title>A Pilot Study Evaluate The Efficacy Adapalene 0.3 % Use Prevention Treatment Senile Purpura</brief_title>
	<detailed_description>This new potential use product Adapalene 0.3 % , currently FDA approve topical treatment use treatment acne . Senile purpura common sign age appear form dark blotch skin cause bruising . Older adult tend prone bruising , since people age , skin become thinner fragile .</detailed_description>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<criteria>Male female 52 year age sign senile purpura either right left ( ) dorsal hand &amp; extensor forearm desire treatment condition associate age . Women hysterectomy , tubal ligation postmenopausal least one year prior study may enrol . Women childbearing potential pregnant , plan become pregnant study period , lactate may enrol use medically accept contraceptive program initiate least one month prior study entry continue study . Subject willing comply study instruction return clinic require visit . Subject able understand sign IRB approve informed consent form include consent photography . All subject coumadin , heparin , plavix , supplemental herb , vitamin E , empirin , fiorinal , norgesic , forte , percodan , robaxin , nuprin , ansaid , anaprox , clinoril , dolobid , feldene , naprosyn , voltaren , fish oil , oral steroid , daily use aspirin , Motrin , Advil . ( PRN usage exclude ) Prior treatment systemic immunosuppressive therapy include limited chemotherapy agent corticosteroid within 3 month study enrollment prohibit . Clotting abnormality determine screen labs Any history stroke unstable heart disease Participation another clinical trial exposure investigational agent within 30 day prior Screening Visit . Any condition Investigator believe would interfere subject 's ability provide inform consent , comply study instruction , might confound interpretation study result put subject undue risk . Subject pregnant , breastfeed plan pregnancy study . Subject unable communicate cooperate Investigator due language barrier ( nonEnglish speaking ) . Subjects allergic adapalene ingredient gel .</criteria>
	<gender>All</gender>
	<minimum_age>52 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Senile Purpura</keyword>
	<keyword>Adapalene 0.3 %</keyword>
</DOC>